Morstyn G, Brown J, Novak U, Gardner J, Bishop J, Garson M
Cancer Res. 1987 Jun 15;47(12):3322-7.
Ten cell lines were established from different biopsies from nine patients with small cell lung cancer (SCLC). These were established from metastases in the marrow (7), breast (1), pleural fluid (1), and spinal cord (1) and had been in culture for periods varying from 1 to 11 months. All cell lines exhibited typical cytological features of SCLC, and produced neuron specific enolase. All lines examined (5) contained dense core granules and were tumorigenic when injected intracranially into nude mice. None of the six cell lines tested had an amplified oncogene (c-myc or n-myc) previously reported to be amplified in SCLC. Detailed chromosome analyses were undertaken and showed that a structural abnormality of chromosome 3(p11p23) was a frequent (6 of 10) but not invariable finding. Our study and one other indicate that there is not a unique chromosome abnormality present in all cases of SCLC, although loss of chromosome 13 and structural abnormalities of chromosome 3 were frequently found. A feature of these SCLC cell lines established from metastatic deposits was the complexity of the karyotypes due to numerical and structural chromosomal abnormalities.
从9例小细胞肺癌(SCLC)患者的不同活检样本中建立了10个细胞系。这些细胞系分别取自骨髓转移灶(7个)、乳腺转移灶(1个)、胸水(1个)和脊髓转移灶(1个),培养时间从1个月到11个月不等。所有细胞系均表现出SCLC典型的细胞学特征,并能产生神经元特异性烯醇化酶。所有检测的细胞系(5个)均含有致密核心颗粒,颅内接种裸鼠时具有致瘤性。所检测的6个细胞系中,均未发现先前报道在SCLC中扩增的癌基因(c-myc或n-myc)。进行了详细的染色体分析,结果显示3号染色体(p11p23)的结构异常较为常见(10个中有6个),但并非所有样本都有。我们的研究以及另一项研究表明,尽管经常发现13号染色体缺失和3号染色体结构异常,但并非所有SCLC病例都存在独特的染色体异常。这些从转移灶建立的SCLC细胞系的一个特点是,由于染色体数目和结构异常,核型较为复杂。